Thalomid (thalidomide capsules) — Cigna

Initial criteria

• Patient has relapsed/refractory or progressive disease OR
• Patient has multi-centric disease AND patient is negative for the human immunodeficiency virus and human herpesvirus-8

Approval duration

1 year